Navigation Links
Review of STAAR's Application for the Visian(R) Toric Implantable Collamer(R) Lens by FDA to Resume
Date:7/21/2009

MONROVIA, Calif., July 21 /PRNewswire-FirstCall/ -- STAAR Surgical Company (Nasdaq: STAA), a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today announced that it has been informed by the U.S. Food and Drug Administration (FDA) Division of Bioresearch Monitoring that the restrictions of the "integrity hold" put in place by the FDA on August 3, 2007 have been removed. The removal of the integrity hold enables the FDA to resume scientific review of the STAAR application for the Toric Implantable Collamer Lens (TICL(TM)) for Myopic/Astigmatic patients. This application is a PMA Supplement to the Visian ICL which the FDA approved on December 22, 2005.

"We are very pleased by the FDA's decision to remove the integrity hold. This very important step in the process is not to be construed as approval of any conditions that may be found in the future, nor should it be construed as clearance to market the Visian Toric ICL," stated Barry G. Caldwell, President &Chief Executive Officer of STAAR Surgical. "The removal does require that any supplement related to the Visian Toric ICL be audited and contain a certification from an independent third party auditor that all data in submission is complete, accurate and reliable. This same standard will be applied to the next subsequent submission for a 510(k), IDE or PMA sent to the FDA by the Company. We believe the outstanding clinical results with this technology are evidenced by the Visian Toric ICL's data. Additional evidence is the acceptance of the technology as more than 150,000 Visian ICLs have been implanted worldwide, of which more than 27,000 have been Visian Toric ICLs outside the U.S. The Visian Toric ICL corrects both myopia and astigmatism with the same procedure," added Mr. Caldwell.


'/>"/>
SOURCE STAAR Surgical Company
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5

Related medicine news :

1. New review suggests caution on drugs to raise good cholesterol
2. Virginia Tech Review Panel Calls For Reform of Mental Health Treatment Law
3. Arbios Systems, Incs Q2/07 Analyst Review Issued by Scimitar Equity Research, Inc.
4. FDA Accepts New Drug Application for Priority Review of Investigational HIV Treatment TMC125
5. FDA Accepts New Drug Application for Priority Review of Investigational HIV Treatment TMC125
6. Peer-Reviewed, Online Database Showcases Local, County and State Pandemic Planning
7. InstaCare Corp. Reviewing M&A Plans
8. CCF Reviews Contents of SCHIP Reauthorization Bill Legislation Places SCHIP on Solid Path
9. Sunrise Provides Status Report on Special Independent Committee Investigation; Provides Updates on Managements Internal Control Review Efforts and on Legal Proceedings
10. Multicountry review shows that Bug Buster Kits reduce head lice and social stigma
11. MaxLife Fund Corp. retains the Law firm, Anslow & Jaclin, LLP of Manalapan, N.J., to review MaxLife Fund Corp. options to be listed on the NASDAQ Capital Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... -- Today, Coastal Healthcare Administrators officially announced ... the first time since its inception in ... will be assuming responsibilities and provider contracts ... Medical Care. ,, Operating on a ... working relationships with all network physicians, ancillary ...
(Date:12/15/2009)... gynaecologist or midwife are generally associated with different ... so much more. Women, doctors and midwives are ... dialogue about sexual health, reveals a thesis from ... Sweden. , Many young women see sex as ... aged 23-29 answered questions about their sex lives, ...
(Date:12/15/2009)... DURHAM, N.C. Scientists seeking to understand how to ... a major roadblock. It turns out that the immune ... manufacture powerful HIV-blocking antibodies but at the same ... sure these cells are eliminated before they have a ... potentially protective neutralizing antibody against a viral disease is ...
(Date:12/15/2009)... about-face, the secretive Central Intelligence Agency has requested documents from ... them from the CIA itself under the Freedom of Information ... ... 15, 2009 -- In a bizarre about-face, the secretive Central ... though the writer had earlier obtained them from the CIA ...
(Date:12/15/2009)... deemed safer than wood fiber , , TUESDAY, Dec. 15 (HealthDay ... arm in a fall are much lower on playgrounds with ... new research has found. , Researchers at the Hospital for ... playground surfaces of either granite sand or engineered wood fiber. ... Medicine . , The risk of a broken arm resulting ...
Breaking Medicine News(10 mins):Health News:Coastal Healthcare Administrators Expands Provider Network to Santa Clara County 2Health News:More about sex and relationships needed at gynecological visits 2Health News:Biological catch-22 prevents induction of antibodies that block HIV 2Health News:CIA Requests its Own Documents from Author 2Health News:CIA Requests its Own Documents from Author 3
... scientists which is reported to be ten times more powerful ... This brings a manned mission to planet Mars closer to ... to accelerate a beam of ions away from the spacecraft ... ESA’s Electric Propulsion Laboratory in the Netherlands have shown that ...
... the latest Journal of Advanced Nursing says expresses deep concern ... the nursing profession. // ,Professor Jill Macleod Clark ... profession to bring about change, the basic problems identified by ... Bendall's paper, which is reprinted in the 30th Anniversary Issue ...
... how the brain functions and converts raw data into ... Zanvyl Krieger Mind/Brain Institute reveals the detailed process in ... the brains visual center is activated and tries to ... converted in the form of an image, which the ...
... disease (cervical cancer) that has been haunting the world. The ... vaccine, // shown to offer protection against 70% of ... (HPV) to the U.S. Food and Drug Administration (FDA). ... approved for use in Europe and other countries excluding the ...
... pan masala and tobacco products near hospitals and educational institutions by ... only from beyond 500 meters from such institutions, according to the ... ensure that this is strictly adhered to. ,The ... the product due its low price and easy availability. Children are ...
... a professor in Penn's Department of Psychology and researcher ... which reported that people couldn’t resist a pretty face. ... positive trait. Participants were given a fraction of a ... ,Participants took very little time in judging attractiveness knowing ...
Other Medicine News:Health News:What nurses learn is not what they practice 2Health News:Understanding “The Brain 2Health News:Cervical Cancer Vaccine Show Promise In Prevention 2Health News:Are pretty faces associated with positive trait? 2
(Date:12/15/2009)... CORALVILLE, Iowa, Dec. 15 Vivakor, ... of Vivakor,s divisions have reported strong performance ... of research and development with divisional spokes ... Vivakor,s R&D Product Pipeline strategy is anchored ... partnering. From idea inception, Vivakor,s R&D efforts ...
(Date:12/15/2009)... Estill Medical Technologies, Inc., a family-owned Texas ... IV Fluid Infusion Warmer , a patented medical device ... and emergency responders to lessen the ... 6 Unit of South Lake Tahoe as the first-ever ... Award." ,, CALSTAR is a California-based nonprofit ...
(Date:12/15/2009)... 15 Rib-X Pharmaceuticals, Inc., a company ... novel drugs for the treatment of serious multi-drug-resistant ... collaborative research agreement with Massachusetts General Hospital (MGH). ... the collaboration, Dr. David Hooper of MGH will ... animal model to determine resistance development and to ...
Breaking Medicine Technology:Vivakor Divisions Continue to Demonstrate Independent Growth 2Thermal Angel Blood Warmer Recognizes CALSTAR 6 With Distinguished Emergency Responder Award 2Thermal Angel Blood Warmer Recognizes CALSTAR 6 With Distinguished Emergency Responder Award 3Thermal Angel Blood Warmer Recognizes CALSTAR 6 With Distinguished Emergency Responder Award 4Rib-X Pharmaceuticals Enters into Collaborative Agreement on Delafloxacin with Massachusetts General Hospital 2Rib-X Pharmaceuticals Enters into Collaborative Agreement on Delafloxacin with Massachusetts General Hospital 3Surety Leads Web Symposium to Address Data Integrity Issues in Bio Sciences Industry 15085 1Surety Leads Web Symposium to Address Data Integrity Issues in Bio Sciences Industry 15085 2Washington Regional Partners with U S Preventive Medicine to Bring a New Level of Preventive Health Care Services to Northwest Arkansas 62791 1Washington Regional Partners with U S Preventive Medicine to Bring a New Level of Preventive Health Care Services to Northwest Arkansas 62791 2Washington Regional Partners with U S Preventive Medicine to Bring a New Level of Preventive Health Care Services to Northwest Arkansas 62791 3VitaminSpice Signs Agreement With Former CEO of Wal Mart Stores Division for US Distribution 62788 1VitaminSpice Signs Agreement With Former CEO of Wal Mart Stores Division for US Distribution 62788 2
... Reduces TNF-alpha Production Through Inhibition,of PDE-4 Enzyme, ... -- Anacor,Pharmaceuticals, a privately held pharmaceutical company, ... 1 trial of,AN2728, a first-in-class topical therapy ... trial showed AN2728 to be,well-tolerated, with activity ...
... and Pharmacokinetics Similar to IV Doses in,Phase ... 06, 2007 /PRNewswire-FirstCall/ --,Genta Incorporated announced the ... Company's lead anti-cancer drug,Genasense(R) (oblimersen sodium) injection, ... injection, as well,as by brief intravenous (IV) ...
Other Medicine Technology:Anacor Clinical Study of AN2728, a Novel Anti-Inflammatory,Compound, Shows Efficacy in Psoriasis 2Genta Announces Results of Phase 1 Study Using Genasense,Administered by Intermittent Subcutaneous Injection 2Genta Announces Results of Phase 1 Study Using Genasense,Administered by Intermittent Subcutaneous Injection 3Genta Announces Results of Phase 1 Study Using Genasense,Administered by Intermittent Subcutaneous Injection 4
Straight shafts with polished finish. Teeth: 0.12 mm. Tying platform: 5.0 mm. Wide Serrated....
Angled 45 degree shafts with 1 x 2 teeth and 5 mm tying platform. Serrated handle with dull finish....
Straight shafts with 1 x 2 teeth and 6 mm tying platform. Wide serrated handle with polished finish....
Straight shafts with 1 x 2 teeth and serrated handle with polished finish....
Medicine Products: